News
Phesi calls for sponsors to rethink ‘primitive’ clinical trial approaches and adopt modal value guided design
Virtual clinical development specialists, Phesi Inc., are calling for clinical trials to be designed using industry modal values (data values that appear most often in historical trials data) to reduce protocol amendments. Phesi analyzed 330,000 clinical trials from the...
News
Prevention-focused model is important in Indian Healthcare Industry
India has actually always believed in a disease prevention model of healthcare -- the Ayurveda system, which relies heavily on keeping one’s body and mind in balance and thus, disease-free. In it, disease treatment also focuses on the root...
News
WHO classifies India Covid strain as ‘variant of concern’
The B-1617 variant of coronavirus, first identified in India, has been classified as a “variant of concern” at the global level by the World Health Organisation (WHO).
Dr Maria Van Kerkhove, Covid-19 Technical Lead at WHO, on Monday said that...
Clinical Trials
INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced positive safety, tolerability and immunogenicity data from its placebo-controlled and blinded Phase 2...
News
I Holland Present their Latest Tablet Tooling Developments to a Virtual Audience at ACHEMA Pulse
I Holland, the world’s best-known manufacturer of tablet punches and dies for the pharmaceutical and nutraceutical industries, has announced it will be exhibiting some of it most innovative products at ACHEMA Pulse from 15-19 June, including the new die...
News
Vaccine Passports in NHS app unethical if they don’t allow date custodianship say FarmaTrust
FarmaTrust, the UK-based global medical supply chain data management provider – has warned that the UK is heading very rapidly down the wrong direction with vaccine passports. The Government last week announced its intention to use the NHS app to...
News
DCGI approves anti-COVID drug developed by DRDO for emergency use
The Drugs Controller General of India has approved an anti-COVID oral drug, developed by DRDO, for emergency use as adjunct therapy in moderate to severe coronavirus patients, the defence ministry said.
It said clinical trials of the drug 2-deoxy-D-glucose (2-DG)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read